Raymond James & Associates Acer Therapeutics Inc. Transaction History

Raymond James & Associates

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$1.98 - $2.98 $32,076 - $48,276	-16,200 Closed	0 $0
Q1 2020 Apr 21, 2020	SELL	$1.18 - $5.86 $590 - $2,930	-500 Reduced 2.99%	16,200 $32,000
Q3 2019 Nov 07, 2019	SELL	$1.95 - $3.93 $285,932 - $576,263	-146,632 Reduced 89.78%	16,700 $53,000
Q2 2019 Aug 06, 2019	BUY	$3.45 - $26.86 $384,364 - $2.99 Million	111,410 Added 214.57%	163,332 $637,000
Q1 2019 May 06, 2019	BUY	$20.4 - $25.15 $1.06 Million - $1.31 Million	51,922 New	51,922 $1.26 Million

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.